Ottawa Heart Institute Research Corporation
Clinical trials sponsored by Ottawa Heart Institute Research Corporation, explained in plain language.
-
Heart drug trial offers hope for millions with long COVID
Disease control Not yet recruitingThis study is testing whether dapagliflozin, a medication typically used for diabetes and heart conditions, can help people with long COVID. Researchers will give 192 participants either the real drug or a placebo pill daily for one year to see if it improves their quality of lif…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Sleep + menopause = double trouble for diabetic Women's hearts?
Knowledge-focused Not yet recruitingThis study aims to understand how menopause and poor sleep together affect heart function in women with type 2 diabetes. Researchers will follow 381 women aged 48-58 who are going through menopause and have diabetes, using heart scans and sleep tracking. The goal is to learn how …
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Heart inflammation mystery: can we predict who gets it again?
Knowledge-focused Not yet recruitingThis study aims to find clues that help doctors predict which patients are at high risk for pericarditis (painful inflammation around the heart) coming back. Researchers will follow 44 adults who have had pericarditis before, using blood tests and special heart scans over one yea…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC